Abstract
Purpose of Review
The purpose of this review is to present an updated view from the epidemiological point of view of the problem of HIV infection in Colombia, highlighting aspects related to the general population, risk factors, discriminated minorities, access to treatment, social factors, resistance, and opportunistic infections.
Recent Findings
Recent data show that in Colombia’s general population, there is a prevalence of HIV infection around 0.6–0.7%, but when we look at high-risk groups like men who have sex with men, it can be as high as 24%; this denotes a marked increase in the epidemic in some subgroups, which goes hand in hand with the increasingly early onset of active sexual life without protection among our adolescents, giving the epidemic an increasingly younger and more feminine face, all this associated with the growing poverty and lack of access to medical services, which necessarily means that we are diagnosing patients in advanced stages of the disease and with a series of opportunistic infections that go according to our epidemiology and geography, highlighting mainly tuberculosis as one of the most frequent.
Summary
The epidemic of HIV in Colombia is increasing, mainly in some specific groups that exert a series of risk factors that facilitate the spread of the infection at an early age. The male:female ratio is still almost 3:1, but a marked increase in infected women is shown through the heterosexual route, which also implies a high risk of vertical transmission, which has decreased in recent years thanks to a series of campaigns aimed at this particular public, but many of our at-risk youth are not becoming aware of safe sex practices and much less are accessing a timely diagnosis, which when done is almost always done in a way delayed, limiting the chances of recovery and adherence to treatment. These findings represent an effort by several government agencies to promote safe sex practices among our youth, easy and quick access to diagnosis, and timely treatment not only of the different opportunistic infections but also of HIV itself, which will necessarily impact the goal of future research, which must surely measure the impact of this whole series of measures.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Vesga JF, Cori A, van Sighem A, Hallett TB. Estimating HIV incidence from case-report data: method and an application in Colombia. AIDS. 2014;28(Suppl 4):S489–96.
Piñeirúa A, Sierra-Madero J, Cahn P, Guevara-Palmero RN, Martínez-Buitrago E, Young B, et al. The HIV care continuum in Latin America: challenges and opportunities. Lancet Infect Dis. 2015;15(7):833–9.
• UNAIDS data 2017, available from http://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf. A very good review with the most updated data on how the HIV epidemic goes in Colombia.
Arrivillaga M, Hoyos PA, Tovar LM, Varela MT, Correa D, Zapata H. HIV testing and counselling in Colombia: evidence from a national health survey and recommendations for health-care services. Int J STD AIDS. 2012;23(11):815–21.
Colombia’s Health Minister. Overview of the HIV/AIDS epidemic in Colombia 2017.
Gómez-Bustamante E, Cogollo-Milanés Z. Secondary student’s knowledge about HIV-AIDS. Rev Salud Pública. 2011;13(5):778–84.
Girón SL, Palacio H, Mateus JC. HIV sexual risk behaviors in youth 15–24 years of age in Cali, Colombia: do differences exist among neighborhoods? Colomb Med. 2013;44(2):72–9.
Rubio Mendoza ML, Jacobson JO, Morales-Miranda S, Sierra Alarcón CÁ, Luque Núñez R. High HIV burden in men who have sex with men across Colombia’s largest cities: findings from an integrated biological and behavioral surveillance study. PLoS One. 2015;10(8):e0131040.
Zea MC, Reisen CA, del Río-González AM, Bianchi FT, Ramirez-Valles J, Poppen PJ. HIV prevalence and awareness of positive serostatus among men who have sex with men and transgender women in Bogotá, Colombia. Am J Public Health. 2015;105(8):1588–95.
Zea MC, Reisen CA, Bianchi FT, Gonzales FA, Betancourt F, Aguilar M, et al. Armed conflict, homonegativity, and forced internal displacement: implications for HIV among Colombian gay, bisexual, and transgender individuals. Cult Health Sex. 2013;15(7):788–803.
Galindo-Quintero J, Mueses-Marin HF, Montaño-Agudelo D, Pinzón-Fernández MV, Tello-Bolívar IC, Alvarado-Llano BE, et al. HIV testing and counselling in Colombia: local experience on two different recruitment strategies to better reach low socioeconomic status communities. AIDS Res Treat. 2014;2014:803685.
Ettenger A, Bärnighausen, Castro A. Health insurance for the poor decreases access to HIV testing in antenatal care: evidence of an unintended effect of health insurance reform in Colombia. Health Policy Plan. 2014;29(3):352–8.
Reisen CA, Zea MC, Bianchi FT, Poppen PJ, del Río González AM, Romero RA, et al. HIV testing among MSM in Bogotá, Colombia: the role of structural and individual characteristics. AIDS Educ Prev. 2014;26(4):328–44.
Varela-Arévalo MT, Hoyos-Hernández PA. Adherence to treatment for HIV/AIDS: beyond the uptake of antiretrovirals. Rev Salud Pública. 2015;17(4):528–40.
Cardona-Arias J, Peláez-Vanegas L, López-Saldarriaga J, Duque-Molina M, Leal-Álvarez O. Health-related quality of life in adults with HIV/AIDS in Colombia. Biomedica. 2011;31:532–44.
Machado-Alba JE, Vidal X. Effectiveness of antiretroviral treatment in Colombia. Rev Panam Salud Publica. 2012;32(5):360–7.
De La Hoz JM, Bolaño L, Cárdenas O, González R, Sabbag J, Palacio L, et al. Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region. Colomb Med (Cali). 2014;45(4):162–7.
DiazGranados CA, Mantilla M, Lenis W. Antiretroviral drug resistance in HIV-infected patients in Colombia. Int J Infect Dis. 2010;14(4):e298–303.
•• Álvarez-Barreneche MF, Restrepo-Castro CA, Hidrón-Botero A, Villa-Franco JP, Trompa-Romero IM, Restrepo-Carvajal L, et al. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia. AIDS Res Ther. 2017;14:60. It shows a very real and accurate vision of the true face of opportunistic infections nowadays in Colombia.
Escandón P, de Bedout C, Lizarazo J, Agudelo CI, Tobón A, Bello S, et al. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006–2010. Biomedica. 2012;32:386–98.
Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, et al. Histoplasmosis: results of the Colombian national survey, 1992–2008. Biomedica. 2011;31(3):344–56.
Caceres DH, Zuluaga A, Arango-Bustamante K, de Bedout C, Tobón ÁM, Restrepo Á, et al. Implementation of a training course increased the diagnosis of histoplasmosis in Colombia. Am J Trop Med Hyg. 2015;93(3):662–7.
Camargo M, Soto-De Leon SC, Muñoz M, Sanchez R, Peña-Herrera D, Pineda-Peña AC, et al. Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia. BMC Cancer. 2014;14:451.
Bautista-Amorocho H, Castellanos-Domínguez YZ, Rodríguez-Villamizar LA, Velandia-Cruz SA, Becerra-Peña JA, Farfán-García AE. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance. PLoS One. 2014;9(12):e114272.
Villa L, Trompa IM, Montes FN, Gómez JG, Restrepo CA. Analysis of mortality caused by tuberculosis in Medellín, Colombia, 2012. Biomedica. 2014;34(3):425–32.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Tropical Diseases in Colombia
Rights and permissions
About this article
Cite this article
Cataño, J.C. HIV in Colombia: an Epidemiologic Point of View. Curr Trop Med Rep 5, 77–84 (2018). https://doi.org/10.1007/s40475-018-0141-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40475-018-0141-y